Which has better valuation and earnings, HIMS or LH?

Labcorp has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hims & Hers Health $2.35B 2.75 $128.37M -$0.63 N/A Labcorp $13.95B 1.90 $876.50M $12.09 27.03

Does the media favor HIMS or LH?

In the previous week, Hims & Hers Health had 47 more articles in the media than Labcorp. MarketBeat recorded 51 mentions for Hims & Hers Health and 4 mentions for Labcorp. Labcorp's average media sentiment score of 0.79 beat Hims & Hers Health's score of 0.16 indicating that Labcorp is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 11 Very Positive mention(s) 5 Positive mention(s) 29 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Neutral Labcorp 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HIMS or DGX?

In the previous week, Hims & Hers Health had 33 more articles in the media than Quest Diagnostics. MarketBeat recorded 51 mentions for Hims & Hers Health and 18 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 1.34 beat Hims & Hers Health's score of 0.16 indicating that Quest Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 11 Very Positive mention(s) 5 Positive mention(s) 29 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Neutral Quest Diagnostics 15 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer GH or HIMS?

In the previous week, Hims & Hers Health had 33 more articles in the media than Guardant Health. MarketBeat recorded 51 mentions for Hims & Hers Health and 18 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.90 beat Hims & Hers Health's score of 0.16 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 10 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Positive Hims & Hers Health 11 Very Positive mention(s) 5 Positive mention(s) 29 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media prefer BTSG or HIMS?

In the previous week, Hims & Hers Health had 40 more articles in the media than BrightSpring Health Services. MarketBeat recorded 51 mentions for Hims & Hers Health and 11 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.41 beat Hims & Hers Health's score of 0.16 indicating that BrightSpring Health Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 11 Very Positive mention(s) 5 Positive mention(s) 29 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Neutral

Hims & Hers Health (HIMS) Competitors

$27.66 -0.16 (-0.58%)

As of 09/4/2026 03:58 PM Eastern

Compare

HIMS vs. LH, DGX, GH, FMS, and BTSG

Should you buy Hims & Hers Health stock or one of its competitors? Hims & Hers Health's main competitors and comparable companies include Labcorp (LH), Quest Diagnostics (DGX), Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), and BrightSpring Health Services (BTSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Hims & Hers Health compare to Labcorp?

Hims & Hers Health (NYSE:HIMS) and Labcorp (NYSE:LH) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

Labcorp has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.75	$128.37M	-$0.63	N/A
Labcorp	$13.95B	1.90	$876.50M	$12.09	27.03

Hims & Hers Health has a beta of 2.42, suggesting that its share price is 142% more volatile than the broader market. Comparatively, Labcorp has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

In the previous week, Hims & Hers Health had 47 more articles in the media than Labcorp. MarketBeat recorded 51 mentions for Hims & Hers Health and 4 mentions for Labcorp. Labcorp's average media sentiment score of 0.79 beat Hims & Hers Health's score of 0.16 indicating that Labcorp is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	11 Very Positive mention(s)	5 Positive mention(s)	29 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral
Labcorp	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 95.9% of Labcorp shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 0.8% of Labcorp shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Labcorp has a net margin of 6.99% compared to Hims & Hers Health's net margin of -5.51%. Labcorp's return on equity of 16.74% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Labcorp	6.99%	16.74%	7.81%

Hims & Hers Health currently has a consensus price target of $32.50, indicating a potential upside of 17.50%. Labcorp has a consensus price target of $330.00, indicating a potential upside of 0.97%. Given Hims & Hers Health's higher possible upside, equities research analysts clearly believe Hims & Hers Health is more favorable than Labcorp.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Labcorp	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75

Summary

Labcorp beats Hims & Hers Health on 11 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to Quest Diagnostics?

Hims & Hers Health (NYSE:HIMS) and Quest Diagnostics (NYSE:DGX) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

Quest Diagnostics has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.75	$128.37M	-$0.63	N/A
Quest Diagnostics	$11.56B	2.26	$992M	$9.42	25.13

Hims & Hers Health has a beta of 2.42, indicating that its share price is 142% more volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market.

Hims & Hers Health currently has a consensus price target of $32.50, indicating a potential upside of 17.50%. Quest Diagnostics has a consensus price target of $235.31, indicating a potential downside of 0.61%. Given Hims & Hers Health's higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than Quest Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54

In the previous week, Hims & Hers Health had 33 more articles in the media than Quest Diagnostics. MarketBeat recorded 51 mentions for Hims & Hers Health and 18 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 1.34 beat Hims & Hers Health's score of 0.16 indicating that Quest Diagnostics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	11 Very Positive mention(s)	5 Positive mention(s)	29 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral
Quest Diagnostics	15 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Quest Diagnostics has a net margin of 9.18% compared to Hims & Hers Health's net margin of -5.51%. Quest Diagnostics' return on equity of 16.01% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Quest Diagnostics	9.18%	16.01%	7.27%

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 0.9% of Quest Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Quest Diagnostics beats Hims & Hers Health on 12 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings.

Hims & Hers Health has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	22.06	-$416.28M	-$3.49	N/A
Hims & Hers Health	$2.35B	2.75	$128.37M	-$0.63	N/A

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Hims & Hers Health has a net margin of -5.51% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

Guardant Health presently has a consensus target price of $183.78, suggesting a potential upside of 13.86%. Hims & Hers Health has a consensus target price of $32.50, suggesting a potential upside of 17.50%. Given Hims & Hers Health's higher possible upside, analysts clearly believe Hims & Hers Health is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

Guardant Health has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.42, meaning that its stock price is 142% more volatile than the broader market.

In the previous week, Hims & Hers Health had 33 more articles in the media than Guardant Health. MarketBeat recorded 51 mentions for Hims & Hers Health and 18 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.90 beat Hims & Hers Health's score of 0.16 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	10 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Positive
Hims & Hers Health	11 Very Positive mention(s)	5 Positive mention(s)	29 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Hims & Hers Health beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Hims & Hers Health (NYSE:HIMS) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

Hims & Hers Health has a beta of 2.42, suggesting that its stock price is 142% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Hims & Hers Health's net margin of -5.51%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.75	$128.37M	-$0.63	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.55	$1.11B	$1.93	11.74

Hims & Hers Health presently has a consensus price target of $32.50, suggesting a potential upside of 17.50%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.57, suggesting a potential upside of 4.00%. Given Hims & Hers Health's stronger consensus rating and higher probable upside, research analysts plainly believe Hims & Hers Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Hims & Hers Health had 50 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 51 mentions for Hims & Hers Health and 1 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.07 beat Hims & Hers Health's score of 0.16 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	11 Very Positive mention(s)	5 Positive mention(s)	29 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Hims & Hers Health and Fresenius Medical Care AG & Co. KGaA tied by winning 8 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Hims & Hers Health (NYSE:HIMS) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership.

BrightSpring Health Services currently has a consensus price target of $70.71, indicating a potential upside of 16.43%. Hims & Hers Health has a consensus price target of $32.50, indicating a potential upside of 17.50%. Given Hims & Hers Health's higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19

BrightSpring Health Services has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	0.93	$190.67M	$1.66	36.58
Hims & Hers Health	$2.35B	2.75	$128.37M	-$0.63	N/A

In the previous week, Hims & Hers Health had 40 more articles in the media than BrightSpring Health Services. MarketBeat recorded 51 mentions for Hims & Hers Health and 11 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.41 beat Hims & Hers Health's score of 0.16 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	11 Very Positive mention(s)	5 Positive mention(s)	29 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral

BrightSpring Health Services has a beta of 1.84, indicating that its stock price is 84% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.42, indicating that its stock price is 142% more volatile than the broader market.

BrightSpring Health Services has a net margin of 2.55% compared to Hims & Hers Health's net margin of -5.51%. BrightSpring Health Services' return on equity of 16.73% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.55%	16.73%	5.24%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

63.5% of Hims & Hers Health shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

BrightSpring Health Services beats Hims & Hers Health on 11 of the 17 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIMS vs. The Competition

Export

Metric	Hims & Hers Health	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$6.49B	$10.10B	$7.28B	$23.69B
Dividend Yield	N/A	2.59%	2.53%	3.72%
P/E Ratio	-43.90	34.60	272.43	29.32
Price / Sales	2.75	4.90	634.35	19.91
Price / Cash	33.24	121.75	77.39	33.23
Price / Book	19.90	3.99	12.85	7.60
Net Income	$128.37M	$313.25M	$3.48B	$1.07B
7 Day Performance	-4.22%	1.06%	0.99%	-0.05%
1 Month Performance	-12.59%	0.33%	5.49%	-0.24%
1 Year Performance	-42.84%	15.31%	24.34%	12.79%

Hims & Hers Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIMS Hims & Hers Health	2.4864 of 5 stars	$27.66 -0.6%	$32.50 +17.5%	-42.7%	$6.49B	$2.35B	N/A	2,442	Trending News
LH Labcorp	4.0171 of 5 stars	$327.95 -1.4%	$330.00 +0.6%	+18.8%	$26.60B	$13.95B	27.13	71,000
DGX Quest Diagnostics	4.4925 of 5 stars	$236.42 -1.6%	$235.31 -0.5%	+31.4%	$26.09B	$11.04B	25.10	57,000	Positive News Insider Trade
GH Guardant Health	3.0931 of 5 stars	$164.88 +3.7%	$183.78 +11.5%	+163.1%	$22.13B	$982.02M	N/A	2,506	Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	3.1177 of 5 stars	$22.73 0.0%	$23.57 +3.7%	-6.8%	$12.21B	$22.20B	11.78	1,488	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HIMS) was last updated on 9/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hims & Hers Health (HIMS) Competitors

HIMS vs. LH, DGX, GH, FMS, and BTSG

How does Hims & Hers Health compare to Labcorp?

Summary

How does Hims & Hers Health compare to Quest Diagnostics?

Summary

How does Hims & Hers Health compare to Guardant Health?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hims & Hers Health (HIMS) Competitors

HIMS vs. LH, DGX, GH, FMS, and BTSG

How does Hims & Hers Health compare to Labcorp?

Which has better valuation and earnings, HIMS or LH?

Which has more risk and volatility, HIMS or LH?

Does the media favor HIMS or LH?

Do institutionals & insiders have more ownership in HIMS or LH?

Is HIMS or LH more profitable?

Do analysts prefer HIMS or LH?

Summary

How does Hims & Hers Health compare to Quest Diagnostics?

Which has preferable earnings and valuation, HIMS or DGX?

Which has more risk and volatility, HIMS or DGX?

Do analysts rate HIMS or DGX?

Does the media refer more to HIMS or DGX?

Is HIMS or DGX more profitable?

Do institutionals and insiders believe in HIMS or DGX?

Summary

How does Hims & Hers Health compare to Guardant Health?

Which has higher earnings & valuation, GH or HIMS?

Do institutionals & insiders have more ownership in GH or HIMS?

Is GH or HIMS more profitable?

Do analysts prefer GH or HIMS?

Which has more risk and volatility, GH or HIMS?

Does the media prefer GH or HIMS?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Which has more volatility and risk, HIMS or FMS?

Is HIMS or FMS more profitable?

Which has higher earnings and valuation, HIMS or FMS?

Do analysts prefer HIMS or FMS?

Do insiders & institutionals have more ownership in HIMS or FMS?

Does the media favor HIMS or FMS?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Do analysts prefer BTSG or HIMS?

Which has higher valuation & earnings, BTSG or HIMS?

Does the media prefer BTSG or HIMS?

Which has more risk and volatility, BTSG or HIMS?

Is BTSG or HIMS more profitable?

Do institutionals & insiders hold more shares of BTSG or HIMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools